October 10, 2026 04:22 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Restriction, not complete closure’: Supreme Court questions Delhi shutdown ahead of CJP protest | 'Unwarranted': India hits back at JD Vance over ‘indentured servants’ remark amid US Green Card crackdown | US targets Microsoft, Infosys, Tata in green card crackdown | ‘Bold and inventive’: Canadian poet Anne Carson wins 2026 Nobel Prize in Literature | ‘Attempt to destabilise world’s largest democracy’: 42 retired judges rally behind Gyanesh Kumar over ‘vote chori’ row | ‘Vote chor, gaddi chod’: Dhruv Rathee, Prakash Raj join Bengaluru protest against Gyanesh Kumar | India condemns Houthi attacks on Saudi airports, calls targeting of civilian infrastructure unacceptable | Dalal Street bloodbath: Investors lose Rs. 8 lakh crore as Sensex crashes over 1,000 points | Amazon layoffs hit India, US and UK: Fresh job cuts rock e-commerce giant amid festive shopping season | Bollywood mourns Nana Patekar: Anupam Kher, Akshay Kumar, Jr NTR, Suniel Shetty pay emotional tributes
Economic Survey
PIB

National COVID-19 vaccination programme meets its goals by overcoming R&D and logistical challenges, reveals Economic Survey 

| @indiablooms | Jan 31, 2023, at 10:49 pm

New Delhi: Elaborating on success story of India’s National Covid-19 Vaccination Programme, the Economic Survey 2022-23, tabled by Union Minister of Finance and Corporate Affairs Nirmala Sitharaman, says that as on 6 January 2023, India has been able to administer more than 220 crore Covid vaccine doses across the country.

97 per cent of eligible beneficiaries have already received at least one dose of Covid-19 vaccine and around 90 per cent of eligible beneficiaries have received both the doses.

Vaccination for the age group 12-14 years was started on 16 March 2022, followed by the precautionary dose for the age group 18-59 years starting from 10 April 2022.

Also, 22.4 crore precautionary doses have been administered, added the Survey further.

India’s National Covid-19 Vaccination Programme, which is the world’s largest vaccination programme, began on 16 January 2021, initially with the aim of covering the adult population of the country in the shortest possible time.

The programme was expanded to include all persons aged 12 years and above and for the precautionary dose for all persons aged 18 years and above.

The introduction of Covid-19 vaccines entailed many challenges such as research and development for new Covid vaccines, training of more than 2.6 lakh vaccinators and 4.8 lakh other vaccination team members, optimum utilisation of available vaccine, difficult-to reach population, and the need to ensure all essential health services along with scaling up of vaccination programme.

In addition, logistical challenges such as storage and decentralised distribution of vaccines across 29,000 cold chain points, augmenting cold chain capacity, and developing IT platform for registering the beneficiaries and vaccine service delivery, were also noticed.

The programme was able to overcome these challenges and meet its goals within a short time frame.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.